Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Double-Blind Placebo-Controlled Study of CT-P27 in an Influenza Challenge Model
KCT0001180Phase 2Completed
- Sponsor
- Celltrion
- Start
- Feb 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CT-P27 in influenza, sponsored by Celltrion. Started Feb 2014; status: completed.
02
Drugs
CT-P27
03
Conditions
influenza
Beyond the preview
Go deeper on KCT0001180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001180.